The effectiveness of vaccination against influenza in healthy, working adults

New England Journal of Medicine

Volumn 333, Issue 14, 1995, Pages 889-893

  Nichol, Kristin L ^a,c   Lind, April ^a,c   Margolis, Karen L ^b,c   Murdoch, Maureen ^a,c   Mcfadden, Rodney ^b   Hauge, Meri ^a,c   Magnan, Sanne ^c,d   Drake, Mari ^c,e  

^a VA MEDICAL CENTER   (United States)

^b HENNEPIN COUNTY MEDICAL CENTER   (United States)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^d Blue Cross Blue Shield of Minnesota   (United States)

^e American Lung Association   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG COST; DRUG EFFICACY; FATIGUE; FEMALE; FEVER; HEADACHE; HUMAN; HUMAN EXPERIMENT; INFLUENZA; INFLUENZA VACCINATION; MALE; MYALGIA; NORMAL HUMAN; PRIORITY JOURNAL; TREATMENT OUTCOME; WORKER;

ADOLESCENT; ADULT; COST SAVINGS; DOUBLE-BLIND METHOD; EMPLOYMENT; FEMALE; HEALTH CARE COSTS; HEALTH STATUS; HUMAN; INFLUENZA; INFLUENZA VACCINE; MALE; MIDDLE AGE; OFFICE VISITS; PHARYNGITIS; RESPIRATORY TRACT INFECTIONS; SICK LEAVE; SUPPORT, NON-U.S. GOV'T; TREATMENT OUTCOME;

EID: 0029154497     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM199510053331401     Document Type: Article

References (34)

1. LaForce FM, Nichol KL, Cox NJ Influenza: virology, epidemiology, disease, and prevention. Am J Prev Med 1994; 10: Suppl: 31-44
2. Sullivan KM, Monto AS, Longini IM Jr Estimates of the US health impact of influenza. Am J Public Health 1993; 83: 1712-1716
3. Riddiough MA, Sisk JE, Bell JC Influenza vaccination: cost-effectiveness and public policy. JAMA 1983; 249: 3189-3195
4. Prevention and control of influenza: vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 1994; 43: 1-13
5. Feinstein AR. Clinical epidemiology: the architecture of clinical research. Philadelphia: W.B. Saunders, 1985:186.
6. Centers for Disease Control and Prevention. A practical guide to prevention effectiveness: decision and economic analyses. Atlanta: Centers for Disease Control and Prevention, 1994:57-68.
7. Green GP, Becker EH, eds. Employment and earnings. Vol. 42. No. 1. Washington, D.C.: Government Printing Office, 1995:207.
8. Gonzalez ML, ed. Socioeconomic characteristics of medical practice 1995. Chicago: American Medical Association, 1995:98.
9. Clinical trials of influenza vaccine: a progress report to the Medical Research Council by its Committee on Clinical Trials of Influenza Vaccine. BMJ 1953; 2: 1173-1177
10. Clinical trials of influenza vaccine: third progress report to the Medical Research Council by its Committee on Clinical Trials of Influenza Vaccine. BMJ 1957; 2: 1-7
11. Clinical trials of oil-adjuvant influenza vaccines, 1960-3: report to the Medical Research Council by its Committee on Influenza and Other Respiratory Virus Vaccines. BMJ 1964; 2: 267-271
12. Edmondson WP, Rothenberg R, White PW, Gwaltney JM Jr A comparison of subcutaneous, nasal, and combined influenza vaccination. II. Protection against natural challenge. Am J Epidemiol 1971; 93: 480-486
13. Edmondson KW, Graham DSM, Warburton MF A clinical trial of influenza vaccine in Canberra. Med J Aust 1970; 2: 6-13
14. Smith JW, Pollard R Vaccination against influenza: a five-year study in the post office. J Hyg (Lond) 1979; 83: 157-170
15. Keitel WA, Cate TR, Couch RB Efficacy of sequential annual vaccination with inactivated influenza virus vaccine. Am J Epidemiol 1988; 127: 353-364
16. Edwards KM, Dupont WD, Westrich MK, Plummer WD Jr, Palmer PS, Wright PF A randomized controlled trial of cold-adapted and inactivated vaccines for the prevention of influenza A disease. J Infect Dis 1994; 169: 68-76
17. Weingarten S, Staniloff H, Ault M, Miles P, Bamberger M, Meyer RD Do hospital employees benefit from the influenza vaccine? A placebo-controlled clinical trial. J Gen Intern Med 1988; 3: 32-37
18. Minnesota Department of Health. Annual summary of communicable diseases reported to the Minnesota Department of Health, 1994. Vol. 23. Disease Control Newsletter. June/July 1995:36.
19. Glezen WP Serious morbidity and mortality associated with influenza epidemics. Epidemiol Rev 1982; 4: 25-44
20. Perrotta DM, Decker M, Glezen WP Acute respiratory disease hospitalizations as a measure of impact of epidemic influenza. Am J Epidemiol 1985; 122: 468-476
21. Lui KJ, Kendal AP Impact of influenza epidemics on mortality in the United States from October 1972 to May 1985. Am J Public Health 1987; 77: 712-716
22. Kochanek KD, Hudson BL. Advance report of final mortality statistics, 1992. Monthly vital statistics report. Vol. 43. No. 6. Suppl. Hyattsville, Md.: National Center for Health Statistics, 1995.
23. National Center for Health Statistics. Vital statistics of the United States. Vol. II. Mortality. Part A, 1979–1992. Compendium. Washington, D.C.: Public Health Service, 1995.
24. Foster DA, Talsma A, Furumoto-Dawson A, Influenza vaccine effectiveness in preventing hospitalization for pneumonia in the elderly. Am J Epidemiol 1992; 136: 296-307
25. Fedson DS, Wajda A, Nicol JP, Hammond GW, Kaiser DL, Roos LL Clinical effectiveness of influenza vaccination in Manitoba. JAMA 1993; 270: 1956-1961 [Erratum, JAMA 1994;271:1578.]
26. Mullooly JP, Bennett MD, Hornbrook MC, Influenza vaccination programs for elderly persons: cost-effectiveness in a health maintenance organization. Ann Intern Med 1994; 121: 947-952
27. Nichol KL, Margolis KL, Wuorenma J, Von Sternberg T The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community. N Engl J Med 1994; 331: 778-784
28. Final results: Medicare influenza vaccine demonstration -- selected states, 1988-1992. MMWR Morb Mortal Wkly Rep 1993; 42: 601-604
29. Schoenbaum SC, McNeil BJ, Kavet J The swine-influenza decision. N Engl J Med 1976; 295: 759-765
30. Schoenbaum SC Economic impact of influenza: the individual's perspective. Am J Med 1987; 82: Suppl 6A: 26-30
31. Yassi A, Kettner J, Hammond G, Cheang M, McGill M Effectiveness and cost-benefit of an influenza vaccination program for health care workers. Can J Infect Dis 1991; 2: 101-108
32. Margolis KL, Nichol KL, Poland GA, Pluhar RE Frequency of adverse reactions to influenza vaccine in the elderly: a randomized, placebo-controlled trial. JAMA 1990; 246: 1139-1141
33. Govaert TM, Dinant GJ, Aretz K, Masurel N, Sprenger MJ, Knottnerus JA Adverse reactions to influenza vaccine in elderly people: a randomised double blind placebo controlled trial. BMJ 1993; 307: 988-990
34. Revicki DA, Irwin D, Reblando J, Simon GE The accuracy of self-reported disability days. Med Care 1994; 32: 401-404